D. Nicholson, A. Ali, N. Thornberry, J. Vaillancourt, C. Ding et al., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature, vol.376, issue.6535, pp.37-43, 1995.
DOI : 10.1038/376037a0

R. Datta, D. Banach, H. Kojima, R. Talanian, E. Alnemri et al., Activation of the CPP32 protease in apoptosis induced by 1-b-D arabinofuranosyl cytosine and other DNA damaging agents, Blood, vol.88, pp.1936-1943, 1996.

K. Wagner, F. King, K. Nomoto, D. Knee, G. Hampton et al., Activation and Suppression of the TRAIL Death-Receptor Pathway in Chemotherapy Sensitive and Resistant Follicular Lymphoma Cells, Cancer Biology & Therapy, vol.2, issue.5, pp.534-540, 2003.
DOI : 10.4161/cbt.2.5.453

K. Debatin, Apoptosis pathways in cancer and cancer therapy, Cancer Immunology, Immunotherapy, vol.53, issue.3, pp.153-159, 2004.
DOI : 10.1007/s00262-003-0474-8

V. Kolenko, R. Uzzo, R. Bukowski, and J. Finke, Caspase-dependent and -independent death pathways in cancer therapy, APOPTOSIS, vol.5, issue.1, pp.17-20, 2000.
DOI : 10.1023/A:1009677307458

I. Mathiasen and M. Jaattela, Triggering caspase-independent cell death to combat cancer, Trends in Molecular Medicine, vol.8, issue.5, pp.212-220, 2002.
DOI : 10.1016/S1471-4914(02)02328-6

R. Ofir, R. Seidman, T. Rabinski, M. Krup, V. Yavelsky et al., Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent, Cell Death and Differentiation, vol.9, issue.6, pp.636-642, 2002.
DOI : 10.1038/sj.cdd.4401012

T. Miller, E. Chase, W. Dalton, and T. Grogan, The phenomenon of multidrug resistance in non-Hodgkin???s lymphoma, Cancer Treat Res, vol.85, pp.107-117, 1996.
DOI : 10.1007/978-1-4615-4129-5_8

Q. Liu, K. Ohshima, and M. Kikuchi, High expression of MDR-1 gene and P-glycoprotein in initial and re-biopsy specimens of relapsed B-cell lymphoma, Histopathology, vol.76, issue.3, pp.209-216, 2001.
DOI : 10.1046/j.1365-2559.2001.01076.x

E. Mechetner, A. Kyshtoobayeva, S. Zonis, H. Kim, R. Stroup et al., Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to paclitaxel and doxorubicin, Clin Cancer Res, vol.4, pp.389-398, 1998.

S. Hegewisch-becker, F. Staib, T. Loning, U. Pichlmeier, N. Kroger et al., No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer, Annals of Oncology, vol.9, issue.1, pp.85-93, 1998.
DOI : 10.1023/A:1008255725515

X. Yang, B. Uziely, S. Groshen, J. Lukas, V. Israel et al., MDR1 gene expression in primary and advanced breast cancer, Lab Invest, vol.79, pp.271-280, 1999.

T. Narita, N. Kimura, M. Sato, N. Matsuura, and R. Kannagi, Altered expression of integrins in adriamycin-resistant human breast cancer cells, Anticancer Res, vol.18, pp.257-262, 1998.

M. De-la-fuente, B. Casanova, E. Cantero, H. Del-cerro, M. Garcia-marco et al., Involvement of p53 in ??4??1 integrin-mediated resistance of B-CLL cells to fludarabine, Biochemical and Biophysical Research Communications, vol.311, issue.3, pp.708-712, 2003.
DOI : 10.1016/j.bbrc.2003.10.054

N. Voorzanger-rousselot, M. Favrot, and J. Blay, Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells, Blood, vol.92, pp.3381-3387, 1998.

N. Voorzanger-rousselot and J. Blay, Coexpression of CD40 and CD40L on B Lymphoma and Carcinoma Cells: an Autocrine Anti-Apoptotic Role, Leukemia & Lymphoma, vol.36, issue.6, pp.1239-1245, 2004.
DOI : 10.1046/j.1365-2141.1998.00522.x

M. Romano, A. Lamberti, P. Tassone, F. Alfinito, S. Costantini et al., Triggering of CD40 antigen inhibits fludarabine-induced apotosis in B chronic leukemia cells, Blood, vol.92, pp.990-995, 1998.

D. De-totero, P. Tazzari, M. Capaia, M. Montera, M. Clavio et al., CD40 triggering enhances fludarabineinduced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation, Haematologica, vol.88, pp.148-158, 2003.

J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J. Galizzi et al., The CD40 Antigen and its Ligand, Annual Review of Immunology, vol.12, issue.1, pp.881-922, 1994.
DOI : 10.1146/annurev.iy.12.040194.004313

J. Schattner, K. Elkon, D. Yoo, J. Tumang, P. Krammer et al., CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway, Journal of Experimental Medicine, vol.182, issue.5, pp.1557-1565, 1995.
DOI : 10.1084/jem.182.5.1557

M. Holder, H. Wang, A. Milner, M. Casamayor, R. Armitage et al., Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction, European Journal of Immunology, vol.147, issue.9, pp.2368-2371, 1993.
DOI : 10.1002/eji.1830230948

P. Johnson, S. Watt, D. Betts, D. Davies, S. Jordan et al., Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system, Blood, vol.82, pp.1848-1857, 1993.

S. Funakoshi, D. Longo, M. Beckwith, D. Conley, G. Tsarfaty et al., Inhibition of human B-cell lymphoma growth by CD40 stimulation, Blood, vol.83, pp.2787-2794, 1994.

C. Buske, A. Twiling, G. Gogowski, K. Schreiber, M. Feuringbuske et al., In vitro activation of low-grade non-Hodgkin???s lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand, Leukemia, vol.11, issue.11, pp.1862-1867, 1997.
DOI : 10.1038/sj.leu.2400822

P. Ghia, V. Boussiotis, J. Schultze, A. Cardoso, D. Dorfman et al., Unbalanced expression of Bcl- 2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival, Blood, vol.91, pp.244-251, 1998.

H. Wang, R. Grand, A. Milner, R. Armitage, J. Gordon et al., Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein, Oncogene, vol.13, pp.373-379, 1996.

N. Andersen, J. Larsen, J. Christiansen, L. Pedersen, N. Christophersen et al., Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures, Blood, vol.96, pp.2219-2225, 2000.

J. Francisco, K. Donaldson, D. Chace, C. Siegall, and A. Wahl, Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14, Cancer Res, vol.60, pp.3225-3231, 2000.

A. Younes and M. Kadin, Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy, Journal of Clinical Oncology, vol.21, issue.18, pp.3526-3534, 2003.
DOI : 10.1200/JCO.2003.09.037

B. Zheng, P. Fiumara, Y. Li, G. Georgakis, V. Snell et al., MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival, Blood, vol.102, issue.3, pp.1019-1027, 2003.
DOI : 10.1182/blood-2002-11-3507

I. Stamenkovic and E. Clark, Seed B: A B lymphocyte activation molecule related to nerve growth factor receptor and induced by cytokines in carcinomas, EMBO J, vol.8, pp.1403-1410, 1989.

R. Vestal, D. Wingett, K. Knight, R. Stillinger, G. Cantor et al., Expression of CD40 in breast, colon, lung and ovarian tumors, Proc Am Assoc Cancer Res, vol.38, p.1550, 1997.

D. Wingett, R. Vestal, K. Forcier, N. Hadjokas, and C. Nielson, CD40 is functionally expressed on human breast carcinomas: Variable inducibility by cytokines and enhancement of Fas-mediated apoptosis, Breast Cancer Research and Treatment, vol.17, issue.1, pp.27-36, 1998.
DOI : 10.1023/A:1006012607452

V. Leoprechting, A. Van-der-bruggen, P. Pahl, H. Aruffo, A. Simon et al., Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis, Cancer Res, vol.59, pp.1287-1294, 1999.

A. Hirano, D. Longo, D. Taub, D. Ferris, L. Young et al., Inhibition of breast carcinoma growth by a soluble recombinant CD40 ligand, Blood, vol.93, pp.2999-3007, 1999.

S. Ghamande, B. Hylander, E. Oflazoglu, S. Lele, W. Fanslow et al., Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin, Cancer Res, vol.61, pp.7556-7562, 2001.

H. Yamaguchi, F. Tanaka, N. Sadanaga, M. Ohta, H. Inoue et al., Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells, International Journal of Oncology, vol.23, pp.1697-1702, 2003.
DOI : 10.3892/ijo.23.6.1697

S. Stumm, A. Meyer, M. Lindner, G. Bastert, D. Wallwiener et al., Paclitaxel Treatment of Breast Cancer Cell Lines Modulates Fas/Fas Ligand Expression and Induces Apoptosis Which Can Be Inhibited through the CD40 Receptor, Oncology, vol.66, issue.2, pp.101-111, 2004.
DOI : 10.1159/000077435

A. Tong, M. Papayoti, G. Netto, D. Armstrong, G. Ordonez et al., Growth-inhibitory effects of CD40 ligand (CD154) and its endogeneous expression in human breast cancer, Clin Cancer Res, vol.7, pp.691-703, 2001.

C. Menetrier-caux, C. Bain, M. Favrot, A. Duc, and J. Blay, Renal cell carcinoma induces interleukin 10 and prostaglandin E2production by monocytes, British Journal of Cancer, vol.79, issue.1, pp.119-130, 1999.
DOI : 10.1038/sj.bjc.6690021

S. Mandlekar, R. Yu, T. Tan, and A. Kong, Activation of caspase-3 and c-jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells, Cancer Res, vol.60, pp.5999-6000, 2000.

B. Bellosillo, M. Dalmau, D. Colomer, and J. Gil, Involvement of CED-3/ ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells, pp.3378-3384, 1997.

R. Jänicke, I. Engels, T. Dunkern, B. Kaina, K. Schulze-osthoff et al., Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells, Oncogene, vol.20, issue.36, pp.5043-5053, 2001.
DOI : 10.1038/sj.onc.1204659

K. Friedrich, T. Wieder, V. Haefen, C. Radetzki, S. Jänicke et al., Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance, Oncogene, vol.20, issue.22, pp.2749-2760, 2001.
DOI : 10.1038/sj.onc.1204342

C. Blanc, Q. Deveraux, S. Krajewski, R. Jänicke, A. Porter et al., Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells, Cancer Res, vol.60, pp.4386-4390, 2000.

K. Johnson, K. Young, and W. Fan, Agonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy, Clin Cancer Res, vol.5, pp.2559-2565, 1999.

S. Bacus, A. Gudkov, M. Lowe, L. Lyass, Y. Yung et al., Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53, Oncogene, vol.20, issue.2, pp.147-155, 2001.
DOI : 10.1038/sj.onc.1204062

A. Calastretti, A. Bevilacqua, C. Ceriani, S. Vigano, P. Zancai et al., Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase, Oncogene, vol.20, issue.43, pp.6172-6180, 2001.
DOI : 10.1038/sj.onc.1204751

R. Bose, M. Verheij, A. Haimovitz-friedman, K. Scotto, Z. Fuks et al., Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals, Cell, vol.82, issue.3, pp.405-414, 1995.
DOI : 10.1016/0092-8674(95)90429-8

W. Jarvis and S. Grant, The role of ceramide in the cellular response to cytotoxic agents, Current Opinion in Oncology, vol.10, issue.6, pp.552-559, 1998.
DOI : 10.1097/00001622-199811000-00013

A. Tepper, E. De-vries, W. Van-blitterswijk, and J. Borst, Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95-and DNA damage-induced apoptosis

N. Radin, Killing cancer cells by poly-drug elevation of ceramide levels, European Journal of Biochemistry, vol.58, issue.2, pp.193-204, 2001.
DOI : 10.1046/j.1432-1033.2001.01845.x

N. Mizushima, R. Koike, H. Kohsaka, Y. Kushi, S. Handa et al., Ceramide induces apoptosis via CPP32 activation, FEBS Letters, vol.269, issue.2-3, pp.267-271, 1996.
DOI : 10.1016/0014-5793(96)01050-2

S. Gamen, I. Marzo, A. Anel, A. Pineiro, and J. Naval, CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells, FEBS Letters, vol.182, issue.2, pp.232-237, 1996.
DOI : 10.1016/0014-5793(96)00666-7

Y. Kawabata, M. Hirokawa, A. Kitabayashi, T. Horiuchi, J. Kuroki et al., Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: A novel mechanism of nuclear apoptosis resistance, Blood, vol.94, pp.3523-3530, 1999.

M. Hirokawa, Y. Kawabata, and A. Miura, Dysregulation of Apoptosis and a Novel Mechanism of Defective Apoptotic Signal Transduction in Human B-cell Neoplasms, Leukemia & Lymphoma, vol.91, issue.2, pp.243-249, 2002.
DOI : 10.1172/JCI9083

K. Henkels and J. Turchi, Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines, Cancer Res, vol.59, pp.3077-3083, 1999.

M. Choi, L. Boise, A. Gottschalk, J. Quintans, C. Thompson et al., The role of bcl-xL in CD40-mediated rescue from anti-??-induced apoptosis in WEHI-231 B lymphoma cells, European Journal of Immunology, vol.88, issue.5, pp.1352-1357, 1995.
DOI : 10.1002/eji.1830250533

Z. Wang, J. Karras, R. Howard, and T. Rothstein, Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells, J Immunol, vol.155, pp.3722-3725, 1995.

J. Tuscano, K. Druey, A. Riva, J. Pena, C. Thompson et al., Bclx rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center, Blood, vol.88, pp.1359-1364, 1996.

H. Lee, H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng, NF-??B-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes, Proceedings of the National Academy of Sciences, vol.13, issue.4, pp.9136-9141, 1999.
DOI : 10.1101/gad.13.4.382

S. Baker and E. Reddy, Transducers of life and death: TNF receptor superfamily and associated proteins, Oncogene, vol.12, pp.1-9, 1996.

G. Cheng and D. Baltimore, TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation., Genes & Development, vol.10, issue.8, pp.963-973, 1996.
DOI : 10.1101/gad.10.8.963

G. Teoh, Y. Tai, M. Urashima, S. Shirahama, M. Matsuzaki et al., activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines, Blood, vol.95, pp.401039-1046, 2000.